-
News | 2024.07.19
Paris 2024: Nathalie Denoyés carrying the torch and upholding the values of the Olympic movement
Throughout this special Paris Games , we are pleased to present some of the Institut Pasteur staff who are playing a special role in this global event – whether in their capacity as an Institut Pasteur staff member, a volunteer or a sports person. We hope that these profiles will showcase the fantastic diversity of the Institut Pasteur community. This week, we want to shine a light on the...
-
Article | 2017.03.27
Advice for Professionals
This section is for notaries, legal professionals and asset management experts. This is where you will find helpful information to advise your clients and documentation that may prove useful if you are currently working with the Bequests department on an estate. Two dedicated websites are also available : one for the Conference on philanthropic trusts and one for the Think tank on philanthropic...
-
Portrait | 2024.05.21
Philippe Bousso: harnessing immune responses to combat cancer
Philippe Bousso, an immunologist and technophile with insatiable curiosity, is constantly tackling new challenges in his efforts to combat cancer. Like the characters in the sci-fi film Fantastic Voyage, he and his team use cutting-edge in vivo technologies to observe the ways in which the immune system wages war on cancer cells. For Philippe, creativity and innovation pave the way for new...
-
Document de presse | 2024.11.08
The new face of “MAKE IT ICONIC. Choose France”, Professor Yasmine Belkaid embodies French boldness in the Government's international campaign
Professor Yasmine Belkaid, immunologist and President of the Institut Pasteur, has joined the international attractiveness campaign “MAKE IT ICONIC. Choose France*”, which aims to promote France's boldness and spirit of innovation, by showcasing the country's research, expertise, know-how and economic strength.A joint project between the French Ministry for Europe and Foreign Affairs’ Press and...
-
Document de presse | 2025.05.23
Launch of the European Vaccines Hub for Pandemic Readiness, a new European public-private partnership for public health-relevant vaccine development
The Health Emergency Preparedness and Response Authority (HERA) of the European Commission, through the European Health and Digital Executive Agency (HaDEA) supports the establishment of the “European Vaccines Hub (EVH) for Pandemic Readiness”, a pan-European center dedicated to advancing public-health–relevant vaccine development. The Grant Agreement has been signed today, marking a...
-
News | 2025.06.12
New identity: restating our commitment to life
The Institut Pasteur, an international center for biomedical research recognized for its contributions to science and public health, has reached a strategic turning point in its history. This has prompted a new visual and narrative identity aimed at strengthening ties with the public.
-
Document de presse | 2017.10.12
Five Institut Pasteur scientists receive 2017 L'Oréal-UNESCO "For Women in Science" Fellowships
On October 11, 2017, five young scientists at the Institut Pasteur received 2017 L'Oréal-UNESCO "For Women in Science" Fellowships. Through their research, the three postdoctoral fellows and two PhD students are helping to advance scientific knowledge in the fields of child malnutrition, the immune system, vaccination, emerging diseases and psychotic disorders. These fellowships, awarded to...
-
Document de presse | 2023.02.20
HIV: third case in the world of probable cure after a bone marrow transplant
Forty years after the discovery of HIV in 1983 at the Institut Pasteur, 38.4 million people were living with the virus worldwide in 2021.[1] Only two cases of people being cured had previously been described: the Berlin patient in 2009 and the London patient in 2019. The IciStem consortium, whose members include Asier Sáez-Cirión's team at the Institut Pasteur, in collaboration with Düsseldorf...
-
Fiche maladie | 2015.10.06
Viral hepatitis
Hepatitis is an inflammation of the liver caused by toxic substances or – in the majority of cases – by viruses. To date, five viruses have been identified that target the liver and cause inflammatory infection. These viruses are referred to by the letters A, B, C, D and E, and vary according to their transmission mode (fecal-oral for A and E, parenteral for B and C) and their aggressive profile.
-
News | 2020.04.14
COVID-19, chronicle of an expected pandemic / Exiting lockdown or the sum total of all dangers
Professor Philippe Sansonetti explains that a lockdown was needed because social distancing measures were not enough on their own. He goes on to outline the conditions that will be required for a future exit strategy – but makes it clear that this strategy will not signal the end of distancing measures. This article was written by Philippe Sansonetti and published on the website "La Vie des...